Table 1.
Condition | Model | Chymase inhibition effects | Reference |
---|---|---|---|
Intermittent Hypoxia | mouse | Decreased perivascular fibrosis and cardiomyocyte hypertrophy, inflammatory cytokines, oxidative stress, Ang II, and superoxide production in LV myocardium | [127] |
Dextran sodium sulfate-induced colitis | mouse | Decreased neutrophil infiltration and MMP-9 activity resulting in improved disease activity index and histological scores | [128] |
Ang II induced aneurysm | ApoE-deficient mouse | Decreased MMP-9 activity and macrophage infiltration. Prevented Ang II-induced aortic aneurysm formation in ApoE-deficient mice | [129] |
Increased salt diet | mouse | Suppressed hypertension and decreased plasma Ang II and aldosterone | [110] |
Myosin-immunized myocarditis | rat | Decreased MMP-9 activation, TGF-β expression, and macrophage infiltration; Improved survival and LV function 4 weeks after immunization | [130] |
Stroke-Prone SHR | rat | Decreased aortic MMP-9 activity, TNF-α, MCP-1 levels and macrophage infiltration; Improved vascular function in vitro and survival | [113] |
Indomethacin-induced colitis | rat | Decreased intestinal wall MMP-9 activation and myeloperoxidase activity; Decreased intestinal lesions and damage | [131] |
Lipopolysaccharide induced liver injury | hamster | Improved liver function and reduced liver necrosis and fibrosis; Decreased liver MMP-9 activation and myeloperoxidase and TNF-α levels | [132] |
Carbon tetrachloride-induced chronic liver failure | hamster | Decreased liver myofibroblasts and fibrosis and decreased liver Ang II levels | [133] |
Elastase-induced aneurysm formation | hamster | Decreased abdominal aortic aneurysm size and mast cell infiltration | [134] |
Streptozotocin-induced diabetes | hamster | Decreased LV NOX4-induced oxidative stress, malonaldehyde levels, and interstitial fibrosis; Attenuated kidney oxidative stress, decreased renal fibrosis and TGF-β, and improved renal function | [135-137] |
Cigarette smoking and bleomycin-induced lung injury | hamster | Decreased lung TGF-β signaling, ET-1 levels, and pulmonary hypertension and fibrosis | [138, 139] |
Coronary artery ligation | hamster | Improved LV systolic function and hemodynamics, hypertrophy and fibrosis; Improved survival | [90,91,140] |
Obstructed kidney | hamster | Attenuated tubulointerstitial fibrosis and TGF-β and α-smooth muscle actin expression | [141] |
Prolonged high-fat diet | hamster | Prevented lipid deposition in the aortas | [142] |
Cardiac Ischemia Reperfusion | mouse | Decrease infarction size and improved LV function | [94] |
Cardiac Ischemia Reperfusion | pig | Decreased myocardial infarction size and tissue MMP-9 activity | [89] |
Cardiac Ischemia Reperfusion | dog | Decreased troponin, MMP-9 activity, and cardiac interstitial chymase activity and attenuated mitochondrial damage | [88] |
Post-Transmural Myocardial Infarction | human | Did not improve LVEF or LV volumes six months after drug initiation 5-10 days after myocardial infarction | [86,87] |
Hypertension | human | Polygonum inhibition of chymase caused a depressor effect especially in hypertensive subjects with excessive salt intake | [143] |
Carotid artery bypass | dog | Inhibited vascular proliferation in grafted vein | [144] |
Orally active chymase inhibitor | hamster | Suppressed heart chymase activity | [145] |
Abbreviations: LV - Left ventricular, LVEF - Left ventricular ejection fraction, TNF – Tumor necrosis factor, MMP-9 Matrix metallopeptidase 9, MCP-1 - Mast cell protease 1, NOX4 - NADPH oxidase 4, ET-1 – Endothelin 1.